Ads
-
Related paper
- A miRNA-PEPTIDE FUSION AS A VACCINE CANDIDATE AGAINST THE NOVEL CORONAVIRUS (COVID-19). EXOSOMES AS POTENTIAL BIOMARKERS OF SARS-COV-2 IN LUNG: AFTER AND BEFORE VACCINATION LCR_2020_B008-13
- A miRNA-PEPTIDE FUSION AS A VACCINE CANDIDATE AGAINST THE NOVEL CORONAVIRUS (COVID-19)
- A DNA-Peptide Fusion as a Vaccine Candidate against Breast and Ovarian Cancer Metastasis: Consequent Benefit in Certain Lung Cancers
- ESAT-6-Ag85C-polyHistag Antigen Fusion is Potential as Vaccine Candidate for Tuberculosis
- Identification of miR-24 and miR-137 as novel candidate multiple sclerosis miRNA biomarkers using multi-staged data analysis protocol
- No to the Herd Immunity against Novel Coronavirus (SARS-Cov-2) without Vaccination
- In Vitro Responses of Human Peripheral Blood Mononuclear Cells to Candidate Vaccine Based on the M2e Peptide of Influenza Virus
- The COVID-19 Vaccination Debate: Should Patients with Celiac Disease be Vaccinated with COVID-19 Vaccine?
- Design of a new multi-epitope peptide vaccine for non-small cell Lung cancer via vaccinology methods: an in silico study
- A NOVEL VACCINE CANDIDATE WITH DOUBLE ANTIVIRAL ACTIVITY AGAINST THE HIV-1 AND COVID-19